Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Abstract

p53 alterations correlate significantly with resistance to platinum-based chemotherapy, early relapse, and shortened overall survival in ovarian cancer patients in univariate analysis. In multivariable analysis though, p53 was not an independent prognostic factor.